Skip to Content

Rule

Division of Freedom of Information; Change of Office Name, and Removal of Address, Telephone Number, and Fax Number; Technical Amendment

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 68114

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Final rule; technical amendments.

SUMMARY:

The Food and Drug Administration (FDA) is amending the Agency's regulations to change the Division of Freedom of Information's (FOI's) name, and remove the address, telephone number, fax number, and Public Reading Room fax number and room number and replace them with FOI's address located on the Agency's Web site. This action is editorial in nature and is intended to improve the accuracy of the Agency's regulations.

DATES:

This rule is effective November 14, 2014.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Sarah Kotler, Freedom of Information Staff, Food and Drug Administration, 301-796-8975, address available on the Agency's Web site at http://www.fda.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

FDA is making technical amendments in the Agency's regulations under 21 CFR parts 5, 10, 14, 20, 21, 314, 350, 516, and 814 as a result of a recent office move. The office name and address was “Division of Freedom of Information (ELEM-1029), 12420 Parklawn Dr., Element Bldg., Rockville, MD 20857”. The new office name and address is listed on the Agency's Web site at http://www.fda.gov. The Freedom of Information Staff's new Public Reading Room number is listed on the Agency's Web site at http://www.fda.gov. Publication of this document constitutes final action of these changes under the Administrative Procedures Act (5 U.S.C. 553). FDA has determined that notice and public comment are unnecessary because these amendments are merely correcting nonsubstantive errors.

Start List of Subjects

List of Subjects

21 CFR Part 5

  • Authority delegations (Government agencies)
  • Imports
  • Organization and functions (Government agencies)

21 CFR Part 10

  • Administrative practice and procedure
  • News media

21 CFR Part 14

  • Administrative practice and procedure
  • Advisory committees
  • Color additives
  • Drugs
  • Radiation protection

21 CFR Part 20

  • Confidential business information
  • Courts
  • Freedom of Information
  • Government employees

21 CFR Part 21

  • Privacy

21 CFR Part 314

  • Administrative practice and procedure
  • Confidential business information
  • Drugs
  • Reporting and recordkeeping requirements

21 CFR Part 350

  • Labeling
  • Over-the-counter drugs

21 CFR Part 516

  • Administrative practice and procedure
  • Animal drugs
  • Confidential business information
  • Reporting and recordkeeping requirements

21 CFR Part 814

  • Administrative practice and procedure
  • Confidential business information
  • Medical devices
  • Medical research
  • Reporting and recordkeeping requirements
End List of Subjects

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR parts 5, 10, 14, 20, 21, 314, 350, 516, and 814 are amended as follows:

Start Part

PART 5—ORGANIZATION

End Part Start Amendment Part

1. The authority citation for 21 CFR part 5 continues to read as follows:

End Amendment Part Start Authority

Authority: 5 U.S.C. 552; 21 U.S.C. 301-397.

End Authority Start Amendment Part

2. In § 5.1110, revise paragraph (b) to read as follows:

End Amendment Part
FDA public information offices.
* * * * *

(b) Freedom of Information Staff. The Freedom of Information Staff's Public Reading Room is located at the address available on the Agency's Web site at http://www.fda.gov.

* * * * *
Start Part

PART 10—ADMINISTRATIVE PRACTICES AND PROCEDURES

End Part Start Amendment Part

3. The authority citation for 21 CFR part 10 continues to read as follows:

End Amendment Part Start Authority

Authority: 5 U.S.C. 551-558, 701-706; 15 U.S.C. 1451-1461; 21 U.S.C. 141-149, 321-397, 467f, 679, 821, 1034; 28 U.S.C. 2112; 42 U.S.C. 201, 262, 263b, 264.

End Authority
[Amended]
Start Amendment Part

4. Section 10.85 is amended in paragraph (d)(4) by removing “(ELEM-1029)” and adding in its place “(the Freedom of Information Staff's address is available on the Agency's Web site at http://www.fda.gov)”.

End Amendment Part
[Amended]
Start Amendment Part

5. Section 10.90 is amended in paragraph (d) by removing “(ELEM-1029)” and adding in its place “(the Freedom of Information Staff's address is available on the Agency's Web site at http://www.fda.gov)”.

End Amendment Part
[Amended]
Start Amendment Part

6. Section 10.95 is amended in paragraphs (b)(2), (c)(2), (d)(2), (d)(7), and (d)(8) by removing “(ELEM-1029)” and adding in its place “(the Freedom of Information Staff's address is available on the Agency's Web site at http://www.fda.gov)”.

End Amendment Part Start Part

PART 14—PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE

End Part Start Amendment Part

7. The authority citation for 21 CFR part 14 continues to read as follows:

End Amendment Part Start Authority

Authority: 5 U.S.C. App. 2; 15 U.S.C. 1451-1461, 21 U.S.C. 41-50, 141-149, 321-394, 467f, 679, 821, 1034; 28 U.S.C. 2112; 42 U.S.C. 201, 262, 263b, 264; Pub. L. 107-109; Pub. L. 108-155, Pub. L. 113-54.

End Authority
[Amended]
Start Amendment Part

8. Section 14.65 is amended in paragraph (c) by removing “(ELEM-1029)” and by adding in its place “(the Freedom of Information Staff's address is available on the Agency's Web site at http://www.fda.gov)”.

End Amendment Part Start Part

PART 20—PUBLIC INFORMATION

End Part Start Amendment Part

9. The authority citation for 21 CFR part 20 continues to read as follows:

End Amendment Part Start Authority

Authority: 5 U.S.C. 552; 18 U.S.C. 1905; 19 U.S.C. 2531-2582; 21 U.S.C. 321-393, 1401-1403; 42 U.S.C. 241, 242, 242a, 242l, 242n, 243, 262, 263, 263b-263n, 264, 265, 300u-300u-5, 300aa-1.

End Authority
[Amended]
Start Amendment Part

10. Section 20.3 is amended in paragraph (b) by removing “(ELEM-1029), Food and Drug Administration, 12420 Parklawn Dr., Element Bldg., Rockville, MD 20857” and adding in its place ” at the address located on the Agency's Web site at http://www.fda.gov.

End Amendment Part Start Amendment Part

11. In § 20.26, revise paragraph (b) to read as follows:

End Amendment Part
Start Printed Page 68115
Indexes of certain records.
* * * * *

(b) Each such index will be made available by accessing the Agency's Web site at http://www.fda.gov. A printed copy of each index is available by writing or visiting the Freedom of Information Staff's address on the Agency's Web site at http://www.fda.gov.

[Amended]
Start Amendment Part

12. Section 20.30 is amended in paragraph (a) by removing “(ELEM-1029), Food and Drug Administration, 12420 Parklawn Dr., Element Bldg., Rockville, MD 20857” and adding in its place “at the address located on the Agency's Web site at http://www.fda.gov.

End Amendment Part Start Amendment Part

13. In § 20.40, revise paragraph (a) to read as follows:

End Amendment Part
Filing a request for records.

(a) All requests for Food and Drug Administration records shall be made in writing by mailing or delivering the request to the Freedom of Information Staff at the address on the Agency's Web site at http://www.fda.gov or by faxing it to the fax number listed on the Agency's Web site at http://www.fda.gov. All requests must contain the postal address and telephone number of the requester and the name of the person responsible for payment of any fees that may be charged.

* * * * *
[Amended]
Start Amendment Part

14. Section 20.107 is amended in paragraph (a) by removing “(ELEM-1029), Food and Drug Administration, 12420 Parklawn Dr., Element Bldg., Rockville, MD 20857” and adding in its place “at the address located on the Agency's Web site at http://www.fda.gov.

End Amendment Part Start Amendment Part

15. In § 20.120, revise paragraph (a) to read as follows:

End Amendment Part
Records available in Food and Drug Administration Public Reading Rooms.

(a) The Freedom of Information Staff and the Division of Dockets Management Public Reading Room are located at the same address. Both are located in rm. 1061, 5630 Fishers Lane, Rockville, MD 20852. The telephone number for the Division of Docket Management is 301-827-6860; the telephone number for the Freedom of Information Staff's Public Reading Room is located at the address on the Agency's Web site at http://www.fda.gov. Both public reading rooms are open from 9 a.m. to 4 p.m., Monday through Friday, excluding legal public holidays.

* * * * *
Start Part

PART 21—PROTECTION OF PRIVACY

End Part Start Amendment Part

16. The authority citation for 21 CFR part 21 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 371; 5 U.S.C. 552, 552a.

End Authority
[Amended]
Start Amendment Part

17. Section 21.32 is amended in paragraph (b)(2) in the second sentence by removing “(HFA-400), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857” and by adding in its place “HR-BETHPL RM7114, HFA-705, 7700 Wisconsin Ave., 7th & 8th floors, Bethesda, MD 20814” and in the third sentence by removing “(ELEM-1029)” and by adding in its place “(the Privacy Act Coordinator is part of the Freedom of Information Staff, the address for which is located on the Agency Web site at http://www.fda.gov)”.

End Amendment Part
[Amended]
Start Amendment Part

18. Section 21.40 is amended in paragraph (b) by removing “(ELEM-1029), Food and Drug Administration, 12420 Parklawn Dr., Element Bldg., Rockville, MD 20857” and by adding in its place “(address is located on the Agency Web site at http://www.gov.fda)”.

End Amendment Part
[Amended]
Start Amendment Part

19. Section 21.41 is amended in paragraphs (c) and (e) by removing “(ELEM-1029)” and by adding in its place “(address is located on the Agency Web site at http://www.gov.fda)”.

End Amendment Part
[Amended]
Start Amendment Part

20. Section 21.43 is amended in paragraph (a)(2) by removing “at the address shown in § 20.30 of this chapter” and by adding in its place “(address is located on the Agency's Web site at http://www.fda.gov)”.

End Amendment Part
[Amended]
Start Amendment Part

21. Section 21.52 is amended in paragraph (a) by removing “, Rm. 14-71, 5600 Fishers Lane, Rockville, MD 20857” and by adding in its place “(see the address on the Agency's Web site at http://www.fda.gov)”.

End Amendment Part Start Part

PART 314—APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG

End Part Start Amendment Part

22. The authority citation for 21 CFR part 314 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 321, 331, 351, 352, 353, 355, 356, 356a, 356b, 356c, 371, 374, 379e.

End Authority Start Amendment Part

23. In § 314.53, in paragraph (e), revise the last sentence to read as follows:

End Amendment Part
Submission of patent information.
* * * * *

(e) * * * A request for copies of the file shall be sent in writing to the Freedom of Information Staff at the address listed on the Agency's Web site at http://www.fda.gov.

* * * * *
Start Part

PART 350—ANTIPERSPIRANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE

End Part Start Amendment Part

24. The authority citation for 21 CFR part 350 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 321, 351, 352, 353, 355, 360, 371.

End Authority
[Amended]
Start Amendment Part

25. Section 350.60 is amended by removing “(ELEM-1029), Food and Drug Administration, 12420 Parklawn Dr., Element Bldg., Rockville, MD 20857” and adding in its place “(address is located on the Agency's Web site at http://www.fda.gov.

End Amendment Part Start Part

PART 516—NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES

End Part Start Amendment Part

26. The authority citation for part 516 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 360ccc-1, 360ccc-2, 371.

End Authority Start Amendment Part

27. In § 516.157, revise paragraph (a) to read as follows:

End Amendment Part
Publication of the index and content of an index listing.

(a) FDA will make the list of indexed drugs available through the FDA Web site at http://www.fda.gov. A printed copy can be obtained by writing to the Freedom of Information Staff or by visiting FDA's Freedom of Information Staff's Public Reading Room at the address listed on the Agency's Web site at http://www.fda.gov.

* * * * *
Start Part

PART 814—PREMARKET APPROVAL OF MEDICAL DEVICES

End Part Start Amendment Part

28. The authority citation for 21 CFR part 814 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 351, 352, 353, 360, 360c-360j, 371, 372, 373, 374, 375, 379, 379e, 381.

End Authority Start Amendment Part

29. In § 814.45, revise paragraph (d)(2) to read as follows:

End Amendment Part
Denial of approval of a PMA.
* * * * *

(d) * * *Start Printed Page 68116

(2) A request for copies of the current PMA approvals and denials document and copies of summaries of safety and effectiveness shall be sent in writing to the Freedom of Information Staff's address listed on the Agency's Web site at http://www.fda.gov.

* * * * *
Start Signature

Dated: November 7, 2014.

Leslie Kux,

Assistant Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 2014-26914 Filed 11-13-14; 8:45 am]

BILLING CODE 4164-01-P